Validation framework for epidemiological models with application to COVID-19 models.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
03 2023
Historique:
received: 28 06 2022
accepted: 22 02 2023
medline: 31 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Mathematical models have been an important tool during the COVID-19 pandemic, for example to predict demand of critical resources such as medical devices, personal protective equipment and diagnostic tests. Many COVID-19 models have been developed. However, there is relatively little information available regarding reliability of model predictions. Here we present a general model validation framework for epidemiological models focused around predictive capability for questions relevant to decision-making end-users. COVID-19 models are typically comprised of multiple releases, and provide predictions for multiple localities, and these characteristics are systematically accounted for in the framework, which is based around a set of validation scores or metrics that quantify model accuracy of specific quantities of interest including: date of peak, magnitude of peak, rate of recovery, and monthly cumulative counts. We applied the framework to retrospectively assess accuracy of death predictions for four COVID-19 models, and accuracy of hospitalization predictions for one COVID-19 model (models for which sufficient data was publicly available). When predicting date of peak deaths, the most accurate model had errors of approximately 15 days or less, for releases 3-6 weeks in advance of the peak. Death peak magnitude relative errors were generally in the 50% range 3-6 weeks before peak. Hospitalization predictions were less accurate than death predictions. All models were highly variable in predictive accuracy across regions. Overall, our framework provides a wealth of information on the predictive accuracy of epidemiological models and could be used in future epidemics to evaluate new models or support existing modeling methodologies, and thereby aid in informed model-based public health decision making. The code for the validation framework is available at https://doi.org/10.5281/zenodo.7102854.

Identifiants

pubmed: 36989251
doi: 10.1371/journal.pcbi.1010968
pii: PCOMPBIOL-D-22-00975
pmc: PMC10057797
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1010968

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Epidemiol Rev. 2022 Jan 14;43(1):166-175
pubmed: 34505122
Lancet Glob Health. 2021 Apr;9(4):e404
pubmed: 33581049
Lancet Infect Dis. 2020 Oct;20(10):1123-1125
pubmed: 32325039
Mater Today Proc. 2020 Dec 9;:
pubmed: 33318952
Philos Trans A Math Phys Eng Sci. 2022 Jan 10;380(2214):20210120
pubmed: 34802273
PLoS Comput Biol. 2022 May 19;18(5):e1010100
pubmed: 35587466
Sci Rep. 2021 Jul 5;11(1):13822
pubmed: 34226584
Chaos Solitons Fractals. 2020 Jun;135:109846
pubmed: 32341628
PLoS Comput Biol. 2021 Jul 26;17(7):e1009149
pubmed: 34310589
PLoS Comput Biol. 2021 Feb 12;17(2):e1008618
pubmed: 33577550
PLoS One. 2021 Feb 22;16(2):e0247456
pubmed: 33617579
Sci Rep. 2020 Dec 3;10(1):21122
pubmed: 33273592
PLoS One. 2021 Jul 26;16(7):e0254999
pubmed: 34310646
Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):9122-9126
pubmed: 32245814
Science. 2020 May 1;368(6490):482-483
pubmed: 32355024
Nat Commun. 2021 May 10;12(1):2609
pubmed: 33972512
Results Phys. 2021 Oct;29:104731
pubmed: 34513578
Lancet Glob Health. 2021 Apr;9(4):e405
pubmed: 33581048
Lancet Glob Health. 2020 Dec;8(12):e1459-e1460
pubmed: 33125915
Comput Biol Med. 2020 Jun;121:103827
pubmed: 32568667
Int J Epidemiol. 2021 Jul 9;50(3):753-767
pubmed: 33837401
Science. 2020 Jul 24;369(6502):413-422
pubmed: 32532802
Cognit Comput. 2021 Feb 19;:1-12
pubmed: 33643473

Auteurs

Kimberly A Dautel (KA)

School of Mathematical Sciences, Rochester Institute of Technology, Rochester, New York, United States of America.
Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, United States of America.

Ephraim Agyingi (E)

School of Mathematical Sciences, Rochester Institute of Technology, Rochester, New York, United States of America.

Pras Pathmanathan (P)

Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH